Tech Company Financing Transactions
4D Path Funding Round
4D Path, based in Newton, secured investment capital from .
Transaction Overview
Company Name
Announced On
5/6/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
No investors have been recorded for this company.
Proceeds Purpose
The company intends to use the funds to accelerate the development of treatment predictive biomarkers for clinical use and partnerships with Biopharma companies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11 John St
Newton, MA 02459
USA
Newton, MA 02459
USA
Phone
Undisclosed
Website
Email Address
Overview
4D Path is Revolutionizing Cancer with Next Generation Tumor Response Prediction; 4D Path is fueling future advances in cancer therapeutics with its QPOR� platform, which is designed to accurately predict a patient's response to cancer treatment from digitized images of a standard H&E-stained biopsy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jacopo Leonardi
Chief Operating Officer
Nicholas Bero
Chief Scientific Officer
Satabhisa Mukhopadhyay
Chief Technical Officer
Tathagata Dasgupta
VP - Engineering
Jonathan Albertelly
Browse more venture capital transactions:
Prev: 5/6/2026: Dandelion Health venture capital transaction
Next: 5/6/2026: Herd Security venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs